SUPERNUS PHARMACEUTICALS INC — Form D/A
SUPERNUS PHARMACEUTICALS INC of ROCKVILLE, MD, a company, filed a Form D amendment with the SEC on 2012-02-16. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-02-16
- Form: D/A
- Accession: 0001356576-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $30.0M
- Amount sold: $30.0M
- Minimum investment: $2.0M
- Investors: 3
- Date of first sale: 2011-01-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-154736
Issuer
- Name: SUPERNUS PHARMACEUTICALS INC
- CIK: 0001356576
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1550 E GUDE DR, ROCKVILLE, MD, 20850
- Phone: 301-838-2500
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| M. James Barrett, Ph.D. | Director | Rockville, MD |
| Michael James Bigham | Director | Rockville, MD |
| Frederick M Hudson | Director | Rockville, MD |
| Jack A Khattar | Director | Rockville, MD |
| Charles W Newhall, III | Director | Rockville, MD |
| William A Nuerge | Director | Rockville, MD |
| Michael B Sheffery, Ph.D. | Director | Rockville, MD |
| John M Siebert | Director | Hayward, CA |
| Paolo P Baroldi, M.D., Ph.D. | Executive Officer | Rockville, MD |
| Padmanabh P Bhatt, Ph.D. | Executive Officer | Rockville, MD |
| Jones W Bryan, Ph.D. | Executive Officer | Rockville, MD |
| Jack A Khattar | Executive Officer | Rockville, MD |
| Tami T Martin, R.N., Esq. | Executive Officer | Rockville, MD |
| Russell P Wilson | Executive Officer | Rockville, MD |
Other filings by this issuer (1)
More